In contrast, the FGFR2-intergenic fusion in lung cancer produced a novel chimeric transcript with a complete kinase domain (FGFR2-PLEKHA4, E17: E10) (Figure S5C-D). The gene discussed is PLEKHA4; the disease is lung carcinoma.